Qube Research & Technologies (QRT) Portfolio holdings
Qube Research & Technologies (QRT) is a British investment firm that trades with computer-driven models and began life inside Credit Suisse. It started in late 2016 as the Qube Fund, run by the bank's asset management unit for model-based strategies, and used computer models to trade stocks. Credit Suisse planned to spin the fund off because rules such as the Volcker Rule restricted banks from trading with their own money, and at the start of 2018 its management team bought the unit and renamed it Qube Research & Technologies. It runs a mix of strategies across many regions, asset classes and time horizons, with research teams of engineers, physicists, mathematicians, data scientists and fundamental analysts.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$1.31B |
| 2 |
NVIDIA
NVDA
|
+$1.03B |
| 3 |
Meta Platforms (Facebook)
META
|
+$840M |
| 4 |
Shopify
SHOP
|
+$815M |
| 5 |
Caterpillar
CAT
|
+$639M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1B |
| 2 |
Chevron
CVX
|
+$834M |
| 3 |
Sandisk
SNDK
|
+$632M |
| 4 |
Intercontinental Exchange
ICE
|
+$490M |
| 5 |
ExxonMobil
XOM
|
+$467M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 20.18% |
| 2 | Technology | 19.85% |
| 3 | Financials | 12.83% |
| 4 | Industrials | 10.55% |
| 5 | Healthcare | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2076
Nexxen International
NEXN
$588M
| $3.16M | ﹤0.01% |
+351,486
| New | +$3.44M |
2026 Q3
0 quarters
|
|
2077
American Integrity Insurance
AII
$547M
| $3.16M | ﹤0.01% |
+126,516
| New | +$2.89M |
2026 Q3
0 quarters
|
|
2078
Distillate US Fundamental Stability & Value ETF
DSTL
$2.2B
| $3.16M | ﹤0.01% |
49,362
+5,001
| +11% | +$330K |
2023 Q4
11 quarters
|
|
2079
CALL
HCA Healthcare
HCA
$104B
| $3.16M | ﹤0.01% |
7,400
-300
| -4% | -$123K |
2024 Q3
8 quarters
|
|
2080
Lamb Weston
LW
$7.72B
| $3.15M | ﹤0.01% |
+75,674
| New | +$3.75M |
2026 Q3
0 quarters
|
|
2081
Q32 Bio
QTTB
$261M
| $3.15M | ﹤0.01% |
+381,469
| New | +$5.28M |
2026 Q3
0 quarters
|
|
2082
Zentalis Pharmaceuticals
ZNTL
$167M
| $3.14M | ﹤0.01% |
1,135,037
+560,231
| +97% | +$2.26M |
2025 Q2
5 quarters
|
|
2083
PUT
Alcoa
AA
$10.5B
| $3.14M | ﹤0.01% |
74,800
-16,100
| -18% | -$768K |
2025 Q1
6 quarters
|
|
2084
Southern California Bancorp
BCAL
$700M
| $3.14M | ﹤0.01% |
146,976
-22,781
| -13% | -$487K |
2025 Q4
3 quarters
|
|
2085
Chatham Lodging
CLDT
$757M
| $3.13M | ﹤0.01% |
+233,588
| New | +$3.07M |
2026 Q3
0 quarters
|
|
2086
CALL
W.W. Grainger
GWW
$69.7B
| $3.11M | ﹤0.01% |
2,500
-400
| -14% | -$528K |
2024 Q4
7 quarters
|
|
2087
Infinite Eagle Acquisition Corp Unit
IEAGU
| $3.11M | ﹤0.01% |
300,000
+424
| +0.1% | +$4.4K |
2026 Q1
2 quarters
|
|
2088
Bicycle Therapeutics
BCYC
$236M
| $3.09M | ﹤0.01% |
840,362
+64,795
| +8% | +$262K |
2026 Q1
2 quarters
|
|
2089
Ranger Energy Services
RNGR
$297M
| $3.09M | ﹤0.01% |
203,554
+30,086
| +17% | +$488K |
2024 Q4
7 quarters
|
|
2090
iShares US Healthcare Providers ETF
IHF
$1.57B
| $3.08M | ﹤0.01% |
+56,080
| New | +$3.18M |
2026 Q3
0 quarters
|
|
2091
CALL
Norwegian Cruise Line
NCLH
$8.25B
| $3.08M | ﹤0.01% |
209,900
-60,600
| -22% | -$1.06M |
2024 Q4
7 quarters
|
|
2092
ProShares UltraPro Short QQQ
SQQQ
$1.69B
| $3.08M | ﹤0.01% |
89,367
+88,820
| +16,238% | +$3.47M |
2026 Q2
1 quarter
|
|
2093
CALL
Microchip Technology
MCHP
$33.6B
| $3.07M | ﹤0.01% |
39,500
+32,800
| +490% | +$2.56M |
2024 Q3
8 quarters
|
|
2094
Alliance Laundry Holdings
ALH
$4.64B
| $3.07M | ﹤0.01% |
+144,202
| New | +$3.49M |
2026 Q3
0 quarters
|
|
2095
Niagen Bioscience
NAGE
$163M
| $3.07M | ﹤0.01% |
1,050,672
-574,344
| -35% | -$1.83M |
2024 Q4
7 quarters
|
|
2096
CALL
Sea Limited
SE
$46.2B
| $3.06M | ﹤0.01% |
31,400
-21,500
| -41% | -$2.36M |
2024 Q4
7 quarters
|
|
2097
ZoomInfo Technologies
GTM
$968M
| $3.06M | ﹤0.01% |
806,350
-16,219
| -2% | -$59K |
2026 Q2
1 quarter
|
|
2098
Banco Santander Chile
BSAC
$15.3B
| $3.05M | ﹤0.01% |
91,427
-173,368
| -65% | -$5.97M |
2023 Q3
12 quarters
|
|
2099
CALL
Alcon
ALC
$35.6B
| $3.04M | ﹤0.01% |
+47,100
| New | +$3.27M |
2026 Q3
0 quarters
|
|
2100
Grifois
GRFS
$5.91B
| $3.03M | ﹤0.01% |
415,102
+9,015
| +2% | +$68.8K |
2025 Q3
4 quarters
|
|
Similar funds
Qube Research & Technologies (QRT)'s Q3 2026 Portfolio in Review
As of Q3 2026, Qube Research & Technologies (QRT) held 4,268 positions worth $123B, up 14% from $108B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Qube Research & Technologies (QRT) deployed $13.6B of net new capital in Q3 2026, opening 862 new positions and adding to 1,394 existing holdings. Its largest new stake was Caterpillar: 753,166 shares worth $611M.
By sector, the portfolio is most concentrated in Miscellaneous at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1B trimmed.
- Qube Research & Technologies (QRT)'s largest Q3 2026 buy was Caterpillar: 753,166 shares worth $611M.
- Qube Research & Technologies (QRT) added most to Warner Bros in Q3 2026, an estimated $1.31B increase.
- Qube Research & Technologies (QRT)'s biggest Q3 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1B.
- Qube Research & Technologies (QRT) fully exited Intercontinental Exchange in Q3 2026, selling an estimated $490M.
- Qube Research & Technologies (QRT)'s ten largest holdings make up 10% of its $123B portfolio in Q3 2026.
- Qube Research & Technologies (QRT) opened 862 new positions and closed 641 in Q3 2026.
- Qube Research & Technologies (QRT)'s portfolio value rose 14% quarter-over-quarter to $123B.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.